The global prefilled syringes market is expanding as healthcare providers, pharmaceutical companies, and patients increasingly adopt convenient, accurate, and safe drug delivery systems. Rising demand for injectable therapies, the growing prevalence of chronic diseases, increasing adoption of biologics and biosimilars, and the shift toward self-administered treatments are supporting the use of prefilled syringes. Their ready-to-use design can simplify medication administration, improve dosing accuracy, reduce preparation steps, and enhance patient convenience, making them an increasingly important solution across modern healthcare and pharmaceutical applications.

According to Grand View Research, the global prefilled syringes market was valued at USD 8.7 billion in 2025 and is estimated to reach USD 9.5 billion in 2026. The market is projected to reach USD 18.1 billion by 2033, registering a CAGR of 9.7% from 2026 to 2033. This growth reflects increasing demand for advanced drug delivery systems, particularly as pharmaceutical companies expand biologic therapies and healthcare systems place greater emphasis on safe, convenient, and patient-centric treatment options.

Download a free sample copy of the Prefilled Syringes Market report to understand detailed coverage and inclusions in the final report

Core Market Segmentation

• The prefilled syringes market is segmented by type, material, application, distribution channel, and region. By type, the disposable segment dominated the market, accounting for 95.6% of overall revenue in 2025. Disposable prefilled syringes offer convenience, dosing accuracy, and safety while eliminating the need to manually transfer medication from vials or ampoules. Reusable prefilled syringes are also gaining attention because of their potential sustainability benefits.

• By material, glass syringes held the largest market share in 2025, supported by their established use in pharmaceutical drug delivery and compatibility with a wide range of formulations. Plastic syringes are expected to witness strong growth as manufacturers increasingly explore lightweight and durable alternatives for specialized applications.

• By application, vaccines and immunizations held the largest revenue share in 2025. The growing need for efficient vaccination programs and ready-to-administer drug delivery formats is supporting demand for prefilled solutions. Autoimmune diseases are identified as the fastest-growing application area as biologic therapies and self-administered treatments become more widely adopted.

• By distribution channel, hospitals held the largest market share in 2025. Healthcare facilities increasingly use prefilled syringes because they can simplify medication administration, reduce preparation steps, and support safer clinical workflows.

Rising Chronic Disease Burden Drives Demand

The increasing prevalence of chronic diseases is one of the major factors driving the prefilled syringes market. Conditions such as diabetes, cardiovascular diseases, respiratory disorders, autoimmune diseases, and other chronic illnesses often require regular injectable therapies.

The growing elderly population is also contributing to demand. Older adults face a higher risk of developing chronic health conditions and may require repeated medical treatment and hospital services. Prefilled syringes can simplify the administration of injectable medications while helping healthcare professionals and patients achieve more consistent dosing.

Growing Adoption of Self-Administration

The shift toward patient-centric healthcare is creating significant opportunities for prefilled syringes. Patients increasingly prefer treatment options that can be administered conveniently at home instead of requiring frequent hospital visits.

Prefilled syringes are particularly relevant for therapies that require repeated injections. Their ready-to-use format can reduce preparation requirements and improve convenience. The continued development of biologics and biosimilars is further supporting demand for advanced drug delivery systems compatible with sensitive injectable formulations.

Focus on Safety and Needle-Stick Prevention

Safety is another important factor influencing product development. Needle-stick injuries remain a concern for healthcare professionals, encouraging manufacturers to introduce syringes with integrated safety mechanisms.

Innovations include needle shields, retractable needles, and other safety features designed to reduce accidental exposure. Prefilled formats can also reduce the number of preparation and handling steps involved in medication administration, potentially supporting improved workflow efficiency and patient safety.

Looking for more specific insights? Customize this report to suite your business needs

Europe Leads the Regional Landscape

Europe dominated the global prefilled syringes market with a 37.1% revenue share in 2025, according to Grand View Research. The region's position is supported by an established healthcare infrastructure, strong pharmaceutical and biotechnology industries, and growing demand for advanced drug delivery solutions.

The Asia Pacific region is expected to be the fastest-growing regional market from 2026 to 2033. Increasing healthcare expenditure, expanding pharmaceutical manufacturing, rising chronic disease prevalence, and growing adoption of injectable therapies are creating new opportunities across the region. The U.S. held the largest country-level market share in 2025.

Competitive Landscape

The prefilled syringes industry is moderately concentrated, with major companies including:

• Becton, Dickinson and Company (BD)

• Gerresheimer AG

• SCHOTT Pharma

• Stevanato Group

• Nipro Corporation

• Terumo

• MedXL Inc

• West pharmaceuticals

• Fresenius Kabi

• B. Braun SE 

These companies are focusing on advanced glass and polymer syringe technologies, safety mechanisms, manufacturing expansion, partnerships, and solutions designed for biologics, vaccines, and specialty injectable drugs.